The drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguchi said.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

BMO Capital Markets managing director Evan Seigerman sits down with Seana Smith and Brad Smith on the Morning Brief to speak about AbbVie's drug research and product pipeline, especially as sales ...

Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker ... the Tokyo-based company is focused neuromuscular disorders, Chief Medical Officer Tadaaki Taniguchi ...